Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.

Abstract

BACKGROUND:

Bone metastasis is a leading cause of the high mortality rate of prostate cancer (PCa), but curative strategies remain lacking. Recent studies suggest long non-coding RNAs (lncRNAs) may be potential targets to develop drugs. However, PCa bone metastasis-specifically-related lncRNAs were rarely reported. This study aimed to identify crucial lncRNAs and reveal their function mechanisms.

METHODS:

GSE32269 and GSE26964 microarray datasets, downloaded from the Gene Expression Omnibus database, were used to analyze differentially expressed genes (DEGs)/lncRNAs (DELs) and miRNAs (DEMs), respectively. Weighted gene co-expression network analysis was performed to screen PCa bone metastasis-associated modules. The co-expression and competing endogenous RNAs (ceRNAs) networks were constructed to identify hub lncRNAs. Univariate Cox regression analysis was conducted to determine their prognostic values. The correlation of lncRNAs with immune infiltrating cells was analyzed by using Tumor IMmune Estimation Resource. Therapeutic drugs were predicted by querying the Connectivity Map (CMap) and the Comparative Toxicogenomics Database (CTD).

RESULTS:

A total of 18 DELs, 2,614 DEGs and 86 DEMs were screened between bone metastatic and primary PCa samples. Four modules enriched by DEGs were shown to be bone metastasis-associated. LncRNA HCG18 and MCM3AP-AS1 were identified to be important because they existed in both of the co-expression and ceRNA networks (forming the relationship pairs: HCG18/MCM3AP-AS1-KNTC1, MCM3AP-AS1-hsa-miR-508-3p-DTL and HCG18/MCM3AP-AS1-hsa-miR-127-3p-CDKN3). All the genes in these interaction pairs were significantly associated with overall survival of PCa patients. Also, HCG18, MCM3AP-AS1 and their target mRNAs were positively correlated with various tumor-infiltrated immune cells, especially increased M2 macrophages. Valproic acid and trichostatin A may be effective to treat PCa bone metastasis by targeting HCG18 and MCM3AP-AS1.

CONCLUSION:

HCG18 and MCM3AP-AS1 that regulate M2 macrophage infiltration may be important targets to treat PCa bone metastasis and improve prognosis.

• Authors: Yanfang Chen, Zheng Chen, Jian Mo, Mao Pang, Zihao Chen, Feng Feng, Peigen Xie, Bu Yang
• Journal: Technology in cancer research & treatment (Technol Cancer Res Treat) 2021 Jan-Dec Vol. 20 Pg. 1533033821990064 ISSN: 1533-0338 [Electronic] United States
• PMID: 33596783 (Publication Type: Journal Article)

Chemical References

• Biomarkers, Tumor
• MicroRNAs
• RNA, Long Noncoding
• RNA, Messenger

Topics

• Biomarkers, Tumor
• Bone Neoplasms (mortality, pathology, secondary)
• Computational Biology (methods)
• Databases, Genetic
• Drug Discovery (methods)
• Gene Expression Profiling
• Gene Expression Regulation, Neoplastic
• Gene Regulatory Networks
• Humans
• Kaplan-Meier Estimate
• Male
• MicroRNAs
• Prognosis
• Prostatic Neoplasms (genetics, mortality, pathology)
• RNA, Long Noncoding (genetics)
• RNA, Messenger
• Transcriptome
• Tumor-Associated Macrophages (metabolism, pathology)